4.6 Review

The Evolving Landscape of Brain Metastasis

Journal

TRENDS IN CANCER
Volume 4, Issue 3, Pages 176-196

Publisher

CELL PRESS
DOI: 10.1016/j.trecan.2018.01.003

Keywords

-

Categories

Funding

  1. National Cancer Institute [2P30CA008748-48]
  2. Mundipharma
  3. Amgen
  4. German Cancer Aid (Deutsche Krebshilfe), Translational Oncology Program
  5. Prevent Brain Metastasis Consortium
  6. MINECO-Retos [SAF2014-57243-R]
  7. MINECO-Europa Excelencia [SAF2015-62547-ERC]
  8. IX FERO Grant for Research in Oncology
  9. Bristol-Myers Squibb Melanoma Research Alliance Young Investigator Award
  10. Beug Foundation Prize for Metastasis Research
  11. Ramon y Cajal Investigator [RYC-2013-13365]

Ask authors/readers for more resources

Metastasis, involving the spread of systemic cancer to the brain, results in neurologic disability and death. Current treatments are largely palliative in nature; improved therapeutic approaches represent an unmet clinical need. However, recent experimental and clinical advances challenge the bleak long-term outcome of this disease. Encompassing key recent findings in epidemiology, genetics, microenvironment, leptomeningeal disease, neurocognition, targeted therapy, immunotherapy, and prophylaxis, we review preclinical and clinical studies to provide a comprehensive picture of contemporary research and the management of secondary brain tumors.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available